Categories: NewsPharmaceutical

U.S. product recalls reach second-highest level in six years during 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Sedgwick brand protection releases year-in-review analysis of 2024 recall data

MEMPHIS, Tenn., Feb. 13, 2025 /PRNewswire/ — The number of U.S. product recalls remained high during 2024 with more than 3,200 events recorded for the second consecutive year. According to Sedgwick brand protection’s 2025 U.S. State of the Nation Recall Index report, the 3,232 recalls across five key industries represent the second-highest annual total in the past six years. Notably, 2023 and 2024 are the only consecutive years in the past decade in which U.S. recall events have exceeded 3,200. In contrast, the number of defective products recalled in 2024 fell to its lowest level since 2015, with 680.9 million units. This is a significant drop from the nearly 1.5 billion units that were recalled just two years earlier in 2022.

Sedgwick’s quarterly Index report analyzes recall data from the automotive, consumer product, food and drink, pharmaceutical, and medical device industries. This special edition not only includes Q4 events, but also provides a comprehensive year-in-review analysis of 2024 recall data and product safety trends. Multiple industries reached significant recall milestones in 2024. The consumer products sector experienced its second-highest recall total in the past eight years, while the medical device sector recorded a four-year high for recall events.

In contrast, the food and drink industry under the U.S. Department of Agriculture’s (USDA) purview recorded the second lowest annual total in the last decade in 2024, despite setting a six-year high in terms of units impacted. Meanwhile, the pharmaceutical sector hit an 11-year annual low for the number of defective units recalled.

Beyond the recall data and analysis, this report also provides essential insights into the regulatory developments that influenced 2024 and forecasts what stakeholders should anticipate in 2025. Looking back at 2024, litigation emerged as a significant trend, with organizations filing lawsuits against government agencies and regulators pursuing criminal actions against companies and individuals related to recall and product safety issues.

In addition, the food and drink industry faced several major recalls in 2024, driven by safety risks such as lead-contaminated cinnamon and Listeria contamination in deli meats. The impacts of these recalls will likely unfold throughout 2025, as the Food and Drug Administration (FDA) pushes for greater oversight of ingredients and the USDA reviews its inspection and recall procedures.

Artificial intelligence (AI) was another key focus for regulators across industries during 2024. That trend is expected to continue in 2025 as the U.S. looks to keep pace with technological innovations while balancing user safety. It is uncertain if these enforcement and litigation trends will continue in 2025 under a new administration or how regulatory priorities may shift.

“It is difficult to say exactly why the number of units recalled continues to fall while the number of product recalls remains high. Manufacturers may be producing smaller batches, overall production could be down, or improvements in traceability might be allowing companies to more accurately identify defective items,” noted Chris Harvey, Senior Vice President of Brand Protection for Sedgwick. “As the new administration develops its agenda, companies may experience some uncertainty with regulatory priorities. In the face of change, it is essential for companies to continue to routinely plan and practice for product recalls and in-market crises.”

To download the latest U.S. Recall Index report, click here.

The Sedgwick brand protection Recall Index is published every quarter. It is the only report that aggregates and tracks recall data across multiple regulatory agencies and industries to help stakeholders navigate the regulatory environment, product recalls, and other in-market challenges. For more information, visit www.sedgwick.com/brandprotection.

About Sedgwick
Sedgwick is a leading global provider of claims management, loss adjusting and technology-enabled business solutions. The company provides a broad range of resources tailored to clients’ specific needs in casualty, property, marine, benefits, brand protection and other lines. At Sedgwick, caring counts; through the dedication and expertise of over 33,000 colleagues across 80 countries, the company takes care of people and organizations by mitigating and reducing risks and losses, promoting health and productivity, protecting brand reputations, and containing costs that can impact performance. Sedgwick’s majority shareholder is The Carlyle Group; Stone Point Capital LLC, Altas Partners, CDPQ, Onex and other management investors are minority shareholders. For more, see sedgwick.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/us-product-recalls-reach-second-highest-level-in-six-years-during-2024-302375705.html

SOURCE Sedgwick Claims Management Services, Inc.

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

5 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

5 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

8 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

8 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

8 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

8 hours ago